Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
WuXi Biologics Included in Hang Seng Corporate Sustainability Benchmark Index 2025-10-22 08:30
WuXi Biologics Receives MSCI AAA ESG Rating for Third Consecutive Year 2025-10-10 08:30
WuXi Biologics Launches WuXia™4.0, Targeted Integration Cell Line Platform TrueSite TI™，to Accelerate Biologics Development with High Titer and Superior Stability 2025-09-25 19:42
WuXi Biologics Selected as Constituent of FTSE4Good Index Series for Fifth Consecutive Year 2025-09-23 12:00
Three WuXi Biologics Manufacturing Facilities Receive GMP Certification from Türkiye İlaç ve Tıbbi Cihaz Kurumu (TITCK) 2025-09-17 12:00
WuXi Biologics Launches Green CRDMO White Paper to Advance Sustainability in Biologics Industry 2025-09-09 18:00
WuXi Biologics' Near-Term and Net-Zero Targets Approved by SBTi 2025-08-28 17:00
WuXi Biologics Reports Solid 2025 Interim Results 2025-08-19 20:35
WuXi Biologics' WuXiUP™ Accomplishes Automated Continuous Drug Substance Production at Pilot-Scale 2025-08-12 17:00
WuXi Biologics Launches HEK 293 Stable Cell Line Platform WuXia293 Stable for Development and Manufacturing of Difficult-to-Express Molecules 2025-08-11 16:30
WuXi Biologics Named to A List for CDP Supplier Engagement Assessment 2025-08-07 08:30
WuXi Biologics Singapore CRDMO Hub Advances with the Launch of Modular Drug Product Facility Fabrication 2025-07-29 16:00
WuXi Biologics Granted Highest Negligible-Risk ESG Rating from Morningstar Sustainalytics 2025-07-16 18:00
WuXi Biologics Launches Next-Generation Platform WuXiHigh™2.0 for High-Concentration Biologics with Protein Concentration Reaching 230 mg/mL 2025-06-30 19:00
Driving Impact Through Responsibility: WuXi Biologics Releases 2024 Sustainability Report 2025-04-29 18:47
WuXi Biologics Recognized by CDP for Climate Change Leadership for Second Consecutive Year 2025-04-22 16:30
WuXi Biologics Completes First Commercial PPQ Campaign at 15,000L Production Line in Hangzhou Site 2025-04-18 14:30
WuXi Biologics Wins Five Asia-Pacific Biopharma Excellence Awards 2025-04-14 21:07
WuXi Biologics Reports Solid 2024 Annual Results and Expects Accelerated Growth in 2025 2025-03-25 18:30
WuXi Biologics Named to CDP Water Security "A List" for Second Consecutive Year 2025-03-21 08:30
1 2 3 4 5 10